Table 4 Estimates of costs in 2002 prices, health benefits and cost-effectiveness from Bolin et al. [10], assuming a five-year dwell time
Strategy | Cost ($) | Incremental changes in cost ($) | Effectiveness (LYG) | Incremental changes in effectiveness (LYG) | Average cost-effectiveness ratio ($) | Incremental cost-effectiveness ratio ($) |
|---|---|---|---|---|---|---|
| Â | (a) | (b) | (c) | (d) | (a)/(c) | (b)/(d) |
EXISTING PRACTICE | 0 | Â | 0 | Â | (Undefined) | Â |
FOBT3 | 109,167,314 | 109,167,314 | 2,010 | 2,010 | 54,312 | 54,312 |
COL | 195,987,062 | 86,819,748 | 1,166 | -844 | 168,085 | (Simply Dominated) |
FSIG5 | 205,570,434 | 96,403,120 | 3,365 | 1,355 | 61,091 | 71,146 |
FOBT1 | 230,156,355 | 24,585,921 | 4,447 | 1,082 | 51,755 | 22,723 |
DCBE5 | 253,881,621 | 23,725,266 | 5,050 | 603 | 50,274 | 39,345 |
FSIG3 | 271,052,169 | 17,170,548 | 3,909 | -1,141 | 69,341 | (Simply Dominated) |
COL10 | 278,701,522 | 24,819,901 | 3,718 | -1,332 | 74,960 | (Simply Dominated) |
DCBE3 | 307,911,416 | 54,029,795 | 6,184 | 1,134 | 49,792 | 47,645 |
COL5 | 360,264,079 | 52,352,663 | 6,181 | -3 | 58,286 | (Simply Dominated) |
FOBT1+FSIG5 | 364,595,167 | 56,683,751 | 5,849 | -335 | 62,335 | (Simply Dominated) |
FOBT1+DCBE5 | 373,803,843 | 65,892,427 | 6,573 | 389 | 56,870 | 169,389 |
FOBT1+FSIG3 | 420,786,416 | 46,982,573 | 6,032 | -541 | 69,759 | (Simply Dominated) |
FOBT1+DBCE3 | 424,911,339 | 51,107,496 | 7,020 | 447 | 60,529 | 114,334 |